Development and validation of rapid molecular diagnostic test for nCoV19

Informazioni relative al progetto

HG nCoV19 test

ID dell’accordo di sovvenzione: 101003713

DOI 10.3030/101003713

Progetto chiuso

Data della firma CE 13 Maggio 2020

Data di avvio 13 Febbraio 2020

Data di completamento 12 Agosto 2021

Finanziato da

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Costo totale € 931 604,75

Contributo UE € 931 604,75

Coordinato da

HIBERGENE DIAGNOSTICS LIMITED
Ireland

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (6)

initial clinical specificity and and sensitivity data

Prepare summary report of initial clinical sensitivity and specificity

Process and Product Risk Analysis Report

Prepare report on robustness of manufacturing process and assay set up. certain proprietory formulation and manufacturing process data to be kept confidential.

Analytical specificity data

Analytical specificity data produced. Use potential cross reactive respiratory virus samples.

Clinical Validation Plan

Finalise clinical validation plan with Medcaptain and IRCCS

Interim Activity report

Interim Activity Report to summarise activity by the consortia

Clinical Validation Report

Prepare report on diagnostic assay performance based on information to be included in the product Instructions for Use.

Websites, patent fillings, videos etc. (1)

Project Website

Prepare website for disclosure of relevant project data and progress and/or arrange protocol for filing of public data with public repository of COVID 19 as recommended by EU.

Demonstrators, pilots, prototypes (1)

Validation Batches

Manufacture batches of diagnostic kits for validation